Medicare Enrolled
Dr. William Craig, MD
Cardiovascular Disease · Gonzales, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Craig from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Craig? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Craig
Dr. William Craig is a cardiovascular disease in Gonzales, TX, with 20 years in practice. Based on federal Medicare data, Dr. Craig performed 32,739 Medicare services across 10,876 unique beneficiaries.
Between the years covered by Open Payments, Dr. Craig received a total of $250,844 from 34 pharmaceutical and/or device companies across 337 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Craig is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 0% volume in TX$ $250,844 industry payments
Medicare Practice Summary
Medicare Utilization ↗32,739
Medicare services
Top 0% in TX for cardiovascular disease
10,876
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,637 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 9,348 | $0 | $10 |
| Office visit, established patient, complex (40-54 min) | 3,829 | $124 | $223 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 3,354 | $98 | $210 |
| Chronic care management, first 20 min/month | 3,144 | $44 | $95 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 2,571 | $53 | $105 |
| Electrocardiogram (EKG), 12-lead | 1,726 | $10 | $52 |
| Telephone medical discussion with physician, 11-20 minutes | 912 | $67 | $184 |
| Remote patient monitoring management, 20 min/month | 859 | $37 | $100 |
| Office visit, established patient (30-39 min) | 714 | $82 | $167 |
| Echocardiogram, transthoracic | 625 | $142 | $580 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 526 | $22 | $60 |
| Heart rhythm recording of continous external ekg over 8-15 days | 462 | $8 | $45 |
| Heart muscle strain imaging | 406 | $28 | $80 |
| New patient office visit, complex (60-74 min) | 374 | $147 | $315 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 356 | $24 | $60 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 345 | $51 | $438 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 343 | $326 | $964 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 342 | $47 | $177 |
| Advance care planning consultation, first 30 min | 286 | $62 | $175 |
| Prothrombin time test (blood clotting) | 253 | $4 | $40 |
| Hospital follow-up visit, high complexity | 227 | $89 | $238 |
| Regadenoson injection (Lexiscan) for heart stress test | 224 | $44 | $300 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 182 | $5 | $20 |
| EKG interpretation and report | 132 | $6 | $43 |
| Critical care, first 30-74 min | 126 | $157 | $800 |
| Transitional care management services for problem of high complexity | 111 | $209 | $375 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 109 | $39 | $115 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 100 | $601 | $1,200 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 91 | $17 | $67 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 74 | $45 | $142 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 63 | $19 | $60 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 60 | $16 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 60 | $11 | $40 |
| Ultrasound of both sides of head and neck blood flow | 60 | $140 | $500 |
| Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day, if using time, at least 45 minutes | 57 | $73 | $250 |
| Drug infusion during cardiac catheterization | 50 | $74 | $400 |
| Cardiac catheterization | 37 | $215 | $2,195 |
| Initial hospital admission, high complexity | 36 | $130 | $400 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 28 | $50 | $186 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 28 | $16 | $52 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 25 | $14 | $65 |
| New patient office visit (45-59 min) | 24 | $121 | $250 |
| Office visit, established patient (10-19 min) | 19 | $43 | $103 |
| Ultrasonic guidance for blood vessel access | 15 | $11 | $30 |
| Ultrasound of heart for congenital defect, follow-up | 13 | $25 | $400 |
| Transitional care management services for problem of at least moderate complexity | 13 | $156 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.5% high complexity
33.2% medium
64.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$250,844
Total received (2018-2024)
Avg $35,835/year across 7 years
Top 2% in TX for cardiovascular disease
34
Companies
337
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$202,300 (80.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27,712 (11.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,178 (6.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,653 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$203,424
2023$1,299
2022$616
2021$16,615
2020$677
2019$9,789
2018$18,423
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$202,300
Novartis Pharmaceuticals Corporation
$28,015
ENDOTRONIX, INC.
$15,264
CVRx, Inc.
$1,346
Amarin Pharma Inc.
$600
E.R. Squibb & Sons, L.L.C.
$557
Amgen Inc.
$528
Janssen Pharmaceuticals, Inc
$320
PFIZER INC.
$184
Merck Sharp & Dohme Corporation
$180
ARBOR PHARMACEUTICALS, INC.
$145
AstraZeneca Pharmaceuticals LP
$143
Merck Sharp & Dohme LLC
$122
Impulse Dynamics (USA) Inc.
$106
Abbott Laboratories
$103
Medicure Pharma Inc.
$97
Lilly USA, LLC
$91
Azurity Pharmaceuticals, Inc.
$86
Regeneron Healthcare Solutions, Inc.
$85
Kowa Pharmaceuticals America, Inc.
$82
ABIOMED
$72
Arbor Pharmaceuticals, Inc.
$71
SANOFI-AVENTIS U.S. LLC
$50
Gilead Sciences, Inc.
$46
Allergan Inc.
$45
HEARTFLOW, INC.
$42
Boston Scientific Corporation
$35
Biohaven Pharmaceutical Holding Company Ltd.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Otsuka America Pharmaceutical, Inc.
$20
Lundbeck LLC
$13
Bardy Diagnostics, Inc.
$11
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$11
VivaQuant Inc, dba Rhythm Express
$10
Top 3 companies account for 97.9% of total payments
Associated products mentioned in payments ›
ANDEXXA · BELSOMRA · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · CORDELLA PULOMONARY ARTERY PRESSURE SENSOR · CardioMEMS HF System · Carnation Ambulatory Monitor · Corlanor · EDARBI · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FFRct · HMG-CoA reductase inhibitor. · HeartMate · Impella · JARDIANCE · LEQVIO · LifeVest · Livalo · MOUNJARO · NORTHERA · NURTEC ODT · OPTIMIZER · Optimizer · PRALUENT · PRALUENT ALIROCUMAB INJECTION · REXULTI · Repatha · Rhythm Express · SCEMBLIX · VERQUVO · Vascepa · WAINUA · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 2% for cardiovascular disease in TX.
Equivalent to $766 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
1
Per 100K population
5.1
County median income
$59,355
Nearest hospital
MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Craig is a clinical cardiology specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (mixed engagement, top 2%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Craig experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Based on Medicare claims data, Dr. Craig performed 9,348 injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Craig receive payments from pharmaceutical companies?
Yes. Dr. Craig received a total of $250,844 from 34 companies across 337 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Craig's costs compare to other cardiovascular diseases in Gonzales?
Dr. Craig's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Craig) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Gonzales
Browse cardiovascular diseases in Gonzales ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ENDOTRONIX, INC. Payments to Doctors
See all physicians who received payments from ENDOTRONIX, INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology